Medicinal Chemistry Research

, Volume 27, Issue 2, pp 571–582 | Cite as

New series of 4(3H)-quinazolinone derivatives: syntheses and evaluation of antitumor and antiviral activities

  • Samir Y. Abbas
  • Khairy A. M. El-Bayouki
  • Wahid M. Basyouni
  • Eslam A. Mostafa
Original Research


New series of 3-(3-trifluoromethylphenyl)-6-iodo-4(3H)-quinazolinone derivatives bearing thiosemicarbazones, pyrazoles, azomethine moieties at C-2 were synthesized. The obtained products were screened for their expected anticancer activity against; human liver cancer cell line (HepG2), breast cancer cell line (MCF-7) and human lung adenocarcinoma epithelial cell line (A549) tumor cell lines. Cytotoxicity of the synthesized compounds showed good IC50 for some products in comparison with the standard drug, doxorubicin. On the other hand, antiviral activity of the synthesized products against H5N1 showed moderate to weak activity compared to Zanamivir reference drug.


4(3H)-Quinazolinones Thiosemicarbazones Pyrazoles Schiff’s bases Antitumor activity Antiviral activity 



We thank Prof. Dr. Mamdouh M. Ali, Biochemistry Department, National Research Centre, Cairo, Egypt on his help to finish the antitumor part. Also, we thank Prof. Dr. Mohamed A. Ali, Virology Laboratory and Water Pollution Department, National Research Center, Cairo, Egypt on his help to finish the antiviral part.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Supplementary material

44_2017_2083_MOESM1_ESM.pdf (2.4 mb)
Supplementary Information


  1. Abbas SY, El-Bayouki KAM, Basyouni WM (2016) Utilization of isatoic anhydride in the syntheses of various types of quinazoline and quinazolinone derivatives. Synthetic Commun 46(12):993–1035Google Scholar
  2. Abbas SY, Farag AA, Ammar YA, Atrees AA, Mohamed AF, El-Henawy AA (2013) Synthesis, characterization, and antiviral activity of novel fluorinated isatin derivatives. Monatshefte für Chemie - Chemical Monthly 144(11):1725–1733Google Scholar
  3. Al-Omary FAM, Abouzeid LA, Nagi MN, Habib EE, Abdel-Aziz AAM, El-Azab AS, Abdel-Hamide SG, Al-Omar MA, Al-Obaid AM, El-Subbagh HI (2010) Non-classical antifolates. Part 2: Synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones. Bioorg Med Chem 18:2849–2863CrossRefPubMedGoogle Scholar
  4. Al-Rashood ST, Aboldahab IA, Nagi MN, Abouzeid LA, Abdel-Aziz AAM, Abdel-Hamide SG, Youssef KM, Al-Obaid AM, El-Subbagh HI (2006) Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg Med Chem 14:860481CrossRefGoogle Scholar
  5. Aly MM, Mohamed YA, El-Bayouki KAM, Basyouni WM, Abbas SY (2010) Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities-Part-1. Eur J Med Chem 45:3365–3373CrossRefPubMedGoogle Scholar
  6. Ammar YA, Mohamed YA, El-Gaby MSA, Abbas SY (2011) Synthesis of some biologically active 4(3H)-quinazolinones derived from 2,3-pyridine dicarboxylic anhydride. Chem Sci J CSJ 15:1–10Google Scholar
  7. Bridges AJ, Zhou H, Cody DR, Rewcastle GW, McMichael A, Showalter HD, Fry DW, Kraker AJ, Denny WA (1996) Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor. J Med Chem 39:267–276CrossRefPubMedGoogle Scholar
  8. Eckhardt S (2002) Recent Progress in the Development of Anticancer Agents. Curr. Med. Chem. Anti-Canc. Agents Curr Med Chem-Anti-Cancer Agents 2:419–439CrossRefGoogle Scholar
  9. El-Bayouki KAM, Aly MM, Mohamed YA, Basyouni WM, Abbas SY (2011) Novel 4(3H)-quinazolinone containing biologically active thiazole, pyridinone and chromene of expected antitumor and antifungal activity. Eur J Chem 2:455–462CrossRefGoogle Scholar
  10. El-Sharief MAMS, Abbas SY, El-Bayouki KAM, El-Gammal EW (2013) Synthesis of thiosemicarbazones derived from N-(4-hippuric acid) thiosemicarbazide and different carbonyl compounds as antimicrobial agents. Eur J Med Chem 67:263–268CrossRefPubMedGoogle Scholar
  11. Farag A, El Shehry MF, Abbas SY, Atrees AA, Ammar YA (2015) Synthesis of pyrazoles containing benzofuran and trifluoromethyl moieties as possible anti-inflammatory and analgesic agents. Z Naturforsch B 70:519–526CrossRefGoogle Scholar
  12. Farag AA, Khalifa EM, Sadik NA, Abbas SY, Al-Sehemi AG, Ammar YA (2013) Synthesis, characterization and evaluation of some novel 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents. Med Chem Res 22:440–452CrossRefGoogle Scholar
  13. Ford SM, Grabenstein JD (2006) Pandemics, avian influenza A (H5N1), and a strategy for pharmacists. Pharmacotherapy 26:312–322CrossRefPubMedGoogle Scholar
  14. Griffin RJ, Srinivasan S, Bowman K, Calvert AH, Curtin NJ, Newell DR, Pemberton LC, Golding BT (1998) Resistance-Modifying Agents. 5. Synthesis and Biological Properties of Quinazolinone Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase (PARP). J Med Chem 41:5247–5256CrossRefPubMedGoogle Scholar
  15. Hayden FG, Cote KM, Douglas RG (1980) Antimicrob. Agents Chemother 17:865–870CrossRefGoogle Scholar
  16. Kersemaekers AMF, Fleuren GJ, Kenter EG, Van den Broek LJ, Uljee SM, Hermans J, Van de Vijver MJ (1999) Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 5:577–586PubMedGoogle Scholar
  17. Khatab TK, El-Bayouki KAM, Basyouni WM, El-Basyoni FA, Abbas SY, Mostafa EAA (2015) novel series of 2,3-dihydroquinazolin-4(1H)-one derivatives: Efficient one-pot synthesis and evaluation of antitumor and antiviral activity. Res Pharm Bio Chem Sci 6:281–291Google Scholar
  18. Li J, Zheng M, Tang W, He P-L, Zhu W, Li T, Zuo J-P, Liu H, Jiang H (2006) Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities. Bioorg Med Chem Lett 16:5009–5013CrossRefPubMedGoogle Scholar
  19. Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanni ME, Cadoni G, Benedetti-Panici P, Paludetti G, Scambia G, Mancuso S (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74:1253–1257CrossRefPubMedPubMedCentralGoogle Scholar
  20. Mossman TJ (1983) Immunol. Meth. 65:55CrossRefGoogle Scholar
  21. Sharma VM, Prasana P, Adi Seshu KV, Rao CLL, Kumar GS, Narasimhulu CP, Babu PA, Puranik RC, Subramanyam D, Warlu AV, Rajagopal S, Kumar KBS, Ajaykumar R, Rajagopalan R (2002) Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure–activity relationship. Bioorg Med Chem Lett 12:2303–2307CrossRefPubMedGoogle Scholar
  22. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) J Natl Cancer Inst 82:1107–1112CrossRefPubMedGoogle Scholar
  23. Smaill JB, Rewcastle GW, Loo JA, Gries KD, Chan OH, Reyner EL, Lipka E, Showalter HD, Vincent PW, Elliot WL, Denny WA (2000) Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions. J Med Chem 43:1380–1397CrossRefPubMedGoogle Scholar
  24. van Riel D, Munster VJ, de Wit E (2006) H5N1 Virus attachment to lower respiratory tract. Science 312:399–399CrossRefPubMedGoogle Scholar
  25. Wakeling AE, Barker A, Davies DH, Brown DS, Green LR, Cartlidge SA, Woodburn JR (1996) Breast Cancer Res Treat 38:67–73.CrossRefPubMedGoogle Scholar
  26. Webster RG, Govorkova EA (2006) H5N1 influenza--continuing evolution and spread. N Engl J Med 355:2174–2177CrossRefPubMedGoogle Scholar
  27. Wissner A, Berger DM, Boschelli DH, Floyd MB, Greenbertger LM, Tsou H, Upeslacis E, Wang YF, Zhang N (2000) 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-Anilino-6,7-dialkoxyquinazoline inhibitors. J Med Chem 43:3244–3256CrossRefPubMedGoogle Scholar
  28. Zhou J, Ji M, Zhu Z, Cao R, Chen X, Xu B (2017) Discovery of 2-substituted 1H-benzo[d]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity. Eur J Med Chem 132:26–41CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Samir Y. Abbas
    • 1
  • Khairy A. M. El-Bayouki
    • 1
  • Wahid M. Basyouni
    • 1
  • Eslam A. Mostafa
    • 1
  1. 1.Organometallic and Organometalloid Chemistry DepartmentNational Research CentreCairoEgypt

Personalised recommendations